To evaluate relationships between plasma concentrations of belantamab mafodotin, total monoclonal antibody, and its payload and changes in electrocardiogram (ECG) parameters in patients with relapsed or refractory multiple myeloma from… Click to show full abstract
To evaluate relationships between plasma concentrations of belantamab mafodotin, total monoclonal antibody, and its payload and changes in electrocardiogram (ECG) parameters in patients with relapsed or refractory multiple myeloma from the DREAMM‐1 and DREAMM‐2 studies.
Keywords:
dreamm;
multiple myeloma;
refractory multiple;
belantamab mafodotin;
relapsed refractory;
patients relapsed
Journal Title: British Journal of Clinical Pharmacology
Year Published: 2024
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: British Journal of Clinical Pharmacology
Year Published: 2024
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!